Navigation Links
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008

ed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Arena Pharmaceuticals, Inc.

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

Three months ended Year ended

December 31, December 31,

2007 2006 2007 2006

(unaudited) (Note)

Revenues

Total revenues $4,569 $4,699 $19,332 $30,569

Expenses

Research and development 40,690 38,095 149,524 103,388

General and administrative 6,923 5,228 26,571 18,466

Amortization of acquired

technology 384 384 1,537 1,537

Total expenses 47,997 43,707 177,632 123,391

Interest and other income, net 3,042 3,119 15,134 6,574

Net loss (40,386) (35,889) (143,166) (86,248)

Dividends on redeemable

convertible preferred stock (540) (520) (2,114) (2,031)

Net loss allocable to common

stockholders $(40,926) $(36,409) $(145,280) $(88,279)

Net loss per share allocable

to common stockholders,

basic and diluted $(0.60) $(0.73) $(2.31) $(1.89)

Shares used in calculating

net loss per share allocable

to common stockholders, basic

and diluted 68,409 50,108 62,783 46,751

Note: The Condensed Consoli
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
10. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
11. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... The National Model Aviation Museum, located at ... to announce that it has been granted full civilian ... States Air Force. , The certification is the culmination ... spring with an on-site inspection by Sarah Sessions, Museum ... National Museum of the United States Air Force ...
(Date:7/25/2014)... study by researchers from the University of Leicester ... function, unlocking the potential to create new materials ... has been published in the prestigious academic journal ... laser technique to examine in rich detail the ... cluster containing an acetylene molecule and a single ...
(Date:7/25/2014)... California (PRWEB) July 25, 2014 Lawrence ... named to Thomson Reuters list of " The World's ... are part of the 3,000 researchers who were identified ... to recognize those who published the highest-impact work (2002-2012 ... research papers on combustion modeling . , "This ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
Breaking Biology Technology:AMA’s National Model Aviation Museum Granted Full Civilian Museum Certification by the National Museum of the United States Air Force 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4
... Ariz., May 31, 2011 Regal One Corporation (OTCBB:RONE), ... on incubating and bringing public high quality companies, today ... shares of Rampart Detection Systems Ltd Common stock. Regal ... registration statement with the United States Securities and Exchange ...
... Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at ... 7, 2011, at 12:20 p.m. ET / 9:20 a.m. ... Global Life Sciences Conference on Wednesday, June 8, 2011, at 10:00 ... New York.  Daniel M. Bradbury, president and chief executive ...
... RALEIGH, N.C., May 31, 2011 Today, Campbell Alliance released ... latest in its Landmark Study series.  A summary report of ... the firm is sharing a more in-depth presentation of the ... Study explores the factors that have caused major changes in ...
Cached Biology Technology:Regal One Announces Dividend of Rampart Detection Systems Common Stock 2Oncology National Commercial (ONC) Study Outlines 10 Trends Shaping the Market for Oncology Pharmaceutical and Biotech Products 2
(Date:7/27/2014)... have shown the potential for global climate change to ... most part, ignored the interactions between increasing temperature and ... to damage crops. , A new study involving researchers ... significant, suggesting that policymakers need to take both warming ... , The study looked in detail at global production ...
(Date:7/27/2014)... single computer cannot always find the solution a user ... cluster of computers that analyze a massive data set ... history to present you with targeted ads, and how ... movie. But big data is about more than just ... are generating unprecedented quantities of information. That data may ...
(Date:7/25/2014)... first broad-scale estimate of air pollution removal by trees ... trees are saving more than 850 human lives a ... , While trees, pollution removal equated to an average ... impacts of that improvement are substantial. Researchers valued the ... nearly $7 billion every year in a study published ...
Breaking Biology News(10 mins):Study: Climate change and air pollution will combine to curb food supplies 2Study: Climate change and air pollution will combine to curb food supplies 3New tools help neuroscientists analyze 'big data' 2New tools help neuroscientists analyze 'big data' 3New tools help neuroscientists analyze 'big data' 4New tools help neuroscientists analyze 'big data' 5First national study finds trees saving lives, reducing respiratory problems 2
... Bad drivers may in part have their genes to blame, ... a particular gene variant performed more than 20 percent worse on ... test a few days later yielded similar results. About 30 percent ... from the get-go, and they forget more of what they learned ...
... OCTOBER 27, 2009 -- The 2009 Annual Meetings of ... of America (CSSA), and Soil Science Society of America ... Pittsburgh, PA. The meeting,s theme, "Footprints in the Landscape: ... location in the LEED-certified David L. Lawrence Convention Center ...
... WHAT: DigitalPersona Vice President of Marketing, Jim ... the Industry Expert Panel on Endpoint Security. Discussing the ... Fulton will describe how enterprises can address security vulnerabilities ... examine how the implementation of identity-aware security offerings shifts ...
Cached Biology News:Bad driving may have genetic basis, UCI study finds 22009 Annual Meetings emphasize sustainability 2DigitalPersona to Speak at Dallas SecureWorld Expo 2
Human beta IG-H3 MAb (Clone 348506) Keywords: BIGH3, betaIG-H3 Protein Family: Extracellular Matrix Molecules...
Human Siglec-9 Biotinylated Affinity Purified Pab...
... an inhibitor of caspase-3/7 ... of inhibitor required to ... be determined empirically for ... inhibitor is sufficient to ...
Human RELT/TNFRSF19L MAb (Clone 238104)...
Biology Products: